Search

everythinglearnresearchcommunity

for

Search:↓

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

The new patient-controlled expansion technique for breast reconstruction is safe, efficient, and cost-effective.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Using certain hair products may increase breast cancer risk in black women.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Examining more lymph nodes can improve survival rates in breast cancer patients without lymph node involvement.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.